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dialysis and transplantation programs, thereby imposing 
a significant economic burden on the healthcare system. 
Prevention, early detection, and timely intervention are 
the only cost‑effective strategies. CKD can be detected 
using simple laboratory tests, and certain treatments 
can prevent or delay complications of decreased kidney 
function, slow the progression of kidney disease, and 
reduce its associated CVD risk.[4,5] This is especially 
pertinent to developing countries, where support for 
renal replacement therapy is lacking for the vast majority 
of patients with advanced kidney disease due to severe 
financial constraints.[6]
At present, there are only about 80 formally trained 
nephrologists in Pakistan for a population of about 160 
million (the USA has more than 5000 nephrologists for 
a population of about 300 million).[7] Until the public 
health services in Pakistan are developed further, general 
practitioners (GPs) will continue to be the frontline 
caregivers in Pakistan. Using the available evidence‑based 
guidelines, the GPs should be able to detect, monitor, 
and treat CKD early in the course of the disease, thereby 
reducing mortality and improving quality of life for their 
patients. Currently, there has been no study in the region 
Introduction
Chronic kidney disease (CKD) is a major public health 
problem worldwide.[1,2] The social and economic 
implications of CKD are substantial not only due to 
morbidity and mortality associated with the progression 
to kidney failure, but also because of its association with 
accelerated cardiovascular disease (CVD).[3] The ultimate 
outcome of CKD in many patients is the need for renal 
replacement therapy, which necessitates ever‑growing 
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ABSTRACT
Due to lack of adequate number of formally trained nephrologists, many patients with chronic kidney disease (CKD) are seen by 
general practitioners (GPs). This study was designed to assess the knowledge of the GPs regarding identification of CKD and 
its risk factors, and evaluation and management of risk factors as well as complications of CKD. We conducted a cross-sectional 
survey of 232 randomly selected GPs from Karachi during 2011. Data were collected on a structured questionnaire based on the 
kidney disease outcomes and quality initiative recommendations on screening, diagnosis, and management of CKD. A total of 
235 GPs were approached, and 232 consented to participate. Mean age was 38.5 ± 11.26 years; 56.5% were men. Most of the 
GPs knew the traditional risk factors for CKD, i.e., diabetes (88.4%) and hypertension (80%), but were less aware of other risk 
factors. Only 38% GPs were aware of estimated glomerular filtration rate in evaluation of patients with CKD. Only 61.6% GPs 
recognized CKD as a risk factor for cardiovascular disease. About 40% and 29% GPs knew the correct goal systolic and diastolic 
blood pressure, respectively. In all, 41% GPs did not know when to refer the patient to a nephrologist. Our survey identified 
specific gaps in knowledge and approach of GPs regarding diagnosis and management of CKD. Educational efforts are needed 
to increase awareness of clinical practice guidelines and recommendations for patients with CKD among GPs, which may improve 
management and clinical outcomes of this population.
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describing how the GPs are doing in incorporating these 
guidelines in their clinical practice. The current study was 
designed to assess the knowledge of GPs in detection and 
treatment of CKD and to see whether it is in accordance 
with the international guidelines for prevention, early 
detection, and management of CKD.
Materials and Methods
We conducted a cross‑sectional survey of the GPs 
practicing in Karachi to assess their knowledge and 
approach toward the diagnosis and management of CKD.
Survey instrument
We reviewed the official Kidney Disease Outcomes and 
Quality Initiatives (KDOQI) guidelines on screening, 
diagnosis, and management of CKD developed by the 
National Kidney Foundation (NKF).[8] We identified 
themes relevant to GPs providing pre‑dialysis CKD 
care. Data were collected on a structured questionnaire 
developed containing questions on the following basic 
themes:
• Type of practice – location of clinic, duration of 
practice, affiliation with teaching hospitals, additional 
postgraduate qualifications beyond basic medical 
qualification (MBBS), and average number of patients 
seen per day.
• Detection of CKD and its risk factors such as diabetes, 
hypertension, old age, and family history of kidney 
disease.
• Screening for CKD – when to screen patients with 
type 1 and type 2 diabetes.
• Complications of CKD – CVD, hypertension, anemia, 
hyperparathyroidism, etc.
• Management goals in CKD – target systolic and diastolic 
blood pressure (BP), target glycated hemoglobin 
(HbA1c), target serum low‑density lipoprotein (LDL) 
cholesterol, first‑line antihypertensive therapy to 
control both BP and proteinuria, and antihypertensive 
agents routinely used in CKD.
• Referral to a nephrologist – at what level of glomerular 
filtration rate (GFR) a CKD patient should be referred 
to nephrologist.
• Source of information about CKD – medical journals 
and/or continued medical education (CME) activities.
The questionnaire was validated by four consultant 
nephrologists. The questionnaire was pretested in a pilot 
study on 10 GPs and was finalized after necessary changes 
based on the feedback.
Sample size
Based on the assumptions that about 30% of GPs did not 
follow the standard guidelines for prevention, detection, 
and management of CKD, a total of 225 subjects were 
needed for the study. We anticipated a nonresponse rate 
of about 4%, so our required sample size was 234 GPs.
Sampling
We performed a cross‑sectional survey of GPs practicing 
in Karachi during May to June 2011. Karachi is the largest 
and most cosmopolitan city in Pakistan, with a population 
of approximately 18 million. The city is divided into 18 
administrative units known as towns. We obtained a 
comprehensive list of 5000 GPs practicing in Karachi 
from a medical database published in a book form called 
“The Mediguide.” A computer‑generated random sample 
of 234 GPs was selected from this list. The GPs surveyed 
had their practices in 12 of the 18 towns in the city and 
represented all socioeconomic classes. Each GP was 
visited by a trained research officer who administered 
the study questionnaire after obtaining written informed 
consent from the GP. Each GP was given 15‑20 min to 
fill the questionnaire at the spot. In case the selected 
GP was not present, their replacement was chosen from 
the same area. The identity of the GPs was kept strictly 
confidential.
Statistical analysis
All statistical analyses were conducted using the Statistical 
package for social science SPSS (Release 15.0, standard 
version, copyright© SPSS; 1989‑02). A descriptive analysis 
was carried out for demographic characteristics and 
results, and presented as mean ± standard deviation. 
Frequencies and percentage were calculated for gender, 
teaching affiliation, and postgraduate qualifications.
Results
A total of 235 GPs were approached, and 232 consented 
to participate in the survey.
Demographics
Mean age of the GPs (±SD) was 38.5 years (±11.26). Of 
the study GPs, 132 (57%) were men. The average number 
of years since practicing as a GP was 12 (±10) years. The 
average number of patients seen by the GP per day was 
57 (±67). A total of 61 (26.3%) GPs were affiliated with 
teaching hospitals and 71 GPs (30.6%) claimed to hold 
postgraduate qualifications beyond MBBS.
Identification of risk factors and screening
A total of 205 (88.4%) GPs recognized diabetes to be a 
risk factor for CKD, and hypertension was identified as a 
risk factor by 185 GPs (79.7%). However, they were less 
likely to identify other risk factors for CKD, such as age 
older than 60 years (33.6%) and family history of kidney 
disease (42.2%).
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When questioned about as to when to screen patients with 
type 1 diabetes for kidney disease, only 29 GPs (12.5%) 
answered correctly. However, most of them (77.2%) knew 
as to when to screen type 2 diabetics.
Detection of chronic kidney disease and its 
complications
The participants were asked to identify the best method 
to estimate kidney function. Serum creatinine was the 
most common choice (78.1%), followed by 24 h urine 
collection for creatinine clearance (63.8%). Estimated 
glomerular filtration rate (eGFR) using a mathematical 
formula was chosen by only 58 GPs (37.9%).
When asked what conditions were complications of CKD, 
most GPs (83.2%) recognized anemia as a complication. 
Bone disease and secondary hyperparathyroidism were 
identified by 53.4% only and malnutrition by 47.8% GPs. 
Other complications such as volume overload, hyperkalemia, 
metabolic acidosis, and worsening hypertension were 
considered by very few of them [Figure 1]. Only 61.6% GPs 
recognized CKD as a risk factor for CVD.
Management
The correct levels of target systolic and diastolic BP in CKD 
patients were aimed for by only 93 (40.1%) and 67 GPs 
(28.9%), respectively [Figure 2]. Only 107 (46.1%) GPs 
chose Angiotensin converting enzyme inhibitors (ACE) or 
angiotensin receptor blockers (ARBs) when questioned about 
the first‑line therapy to control both BP and proteinuria in 
order to slow down the progression of CKD.
The correct target HbA1c in patients with diabetes and 
CKD was aimed for by 124 GPs (53.4%). However, only 
50 GPs (21.6%) were aware of the correct level of target 
LDL cholesterol in CKD patients.
Referral to a nephrologist
There was uncertainty among the GPs about when to refer 
to a nephrologist. An estimated GFR of 30‑60 ml/min 
was chosen by 23.3% GPs, 15‑29 ml/min by 19.8%, and 
less than 15 ml/min by 15.1% GPs, whereas 40.9% GPs 
responded that they did not know when to refer the 
patient to a nephrologist.
Sources of information
Only half the GPs reported reading medical journals in 
order to keep themselves updated, whereas approximately 
33% GPs claimed to participate in CME activities held at 
various tertiary care hospitals.
Discussion
The results of our GP survey highlight the areas that need 
to be worked upon in order to improve the quality of care 
and outcomes for patients with CKD. In Pakistan, patients 
suffering from CKD are mainly under care of internists 
and GPs until they reach advanced kidney failure when 
they are referred to a nephrologist. Delayed referral of 
CKD patients to a nephrologist has been identified as 
an important predictor of poor outcomes.[9] In order to 
initiate timely referral of CKD patients, primary care 
providers and family physicians need to be aware of risk 
factors for CKD, screening methods, as well as comorbid 
conditions and complications associated with CKD. In 
addition, they should be aware of the clinical practice 
guidelines describing optimal care of patients with CKD. 
The NKF’s KDOQI work‑group released evidence‑based 
guidelines, in 2002, to increase awareness of these 
secondary prevention strategies in the care of CKD.[8] 
These are the only known evidence‑based guidelines for 
pre‑dialysis CKD care. Incorporation of these guidelines 
into clinical practice facilitates early detection of 
CKD by primary care providers and identification and 
management of its complications, and promotes timely 
referral of patients to nephrology services.
Traditionally, physicians have been relying on measurement 
of serum creatinine alone for detection of kidney disease. 
The KDOQI guidelines recommend that serum creatinine 
alone is not an accurate index of the level of GFR and ???????????????????????????????????????? ?????? ????????????????????????????????????????????????????????????????????? ??????????????????????????????????
Figure 1: Proportion of GPs who identified the listed conditions as 
complications of CKD
???????????????????? ???? ??????? ??????? ???? ??? ????? ????? ???????????????????????? ???????? ?????????
Figure 2: Target systolic and diastolic BP (mm of Hg) chosen by the GPs
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that the level of GFR should be estimated from prediction 
equations that take into account the serum creatinine 
concentration and some or all of the following variables: 
Age, gender, race, and body size.[8] Our results indicate 
that only 38% physicians opt for eGFR for detection of 
CKD and most of the GPs preferred serum creatinine 
and/or 24 h urine collection for creatinine clearance. A 
study involving 10 primary care providers from New York 
showed similar findings as far as physicians’ preferences 
for kidney disease diagnostic tests were concerned. Only 
one of the physicians interviewed reported using eGFR,[10] 
whereas the rest of them relied upon blood urea, serum 
creatinine, or urinalysis for diagnosis of CKD. Results 
from a cross‑sectional study, based upon different groups 
of physicians at a tertiary care hospital in Pakistan, 
showed that majority of the study subjects (78%) were 
aware of eGFR being a better way of assessing severity of 
kidney disease than elevated serum creatinine alone.[11] 
Using serum creatinine alone may result in significant 
under‑recognition of CKD as the level may still be within 
normal range even when kidney function is significantly 
impaired. Measurement of creatinine clearance requires 
collection of a timed urine sample, which is inconvenient 
and frequently inaccurate. In order to identify patients 
with early CKD, estimation of GFR using formulae such 
as the Cockcroft–Gault and modification of diet in renal 
disease should be done.
Epidemiologic studies show an increased risk for 
CKD among individuals with certain clinical and 
sociodemographic characteristics, including older age, race 
(African–Americans), diabetes, hypertension, autoimmune 
diseases, urinary tract infections, stone disease, neoplasia, 
family history of CKD, etc.[8] It cannot be overemphasized 
that prevention of adverse outcomes of CKD could be 
facilitated by evaluating individuals with these risk factors 
to enable earlier detection and intervention. In our survey, 
diabetes and hypertension were identified as risk factors for 
CKD by most of the physicians, whereas other risk factors 
for CKD such as age older than 60 years and family history 
of kidney disease did not receive the same recognition. 
Data from a web‑based survey in the USA, which included 
376 family medicine and internal medicine trainees, 
show similar results.[12] Whereas almost all physicians 
identified diabetes and hypertension as strong risk factors 
for CKD, minority status, old age, or family history were 
not universally recognized. The authors speculated that it 
would be more challenging to emphasize the contribution 
of risk factors such as race, ethnicity, and old age, because 
of the varying prevalence of comorbid diseases such as 
hypertension.
The American Diabetes Association and the KDOQI 
work‑group recommend that patients with diabetes 
should be screened annually for diabetic kidney 
disease.[13] Initial screening should commence 5 years 
after the diagnosis of type 1 diabetes and at the time of 
diagnosis of type 2 diabetes. It is disappointing that almost 
88% of the GPs surveyed do not know as to when to start 
screening type 1 diabetics for the presence of kidney 
disease. However, most of the physicians were aware of 
screening patients with type 2 diabetes, which is the more 
prevalent form of the disease. As far as management of 
diabetic patients with CKD was concerned, only half the 
GPs identified the correct target HbA1c. It is of particular 
concern because diabetes is the leading cause of kidney 
failure worldwide, and the prevalence is high in the South 
Asian populations and is expected to increase two‑fold 
between 2000 and 2030.[14] Appropriate screening, early 
detection, and timely intervention including management 
of diabetes and hypertension are the only strategies 
that can slow kidney disease progression and reduce 
cardiovascular risk. In 2007, the KDOQI work‑group 
released evidence‑based clinical practice guidelines and 
clinical practice recommendations for screening and 
management of patients with diabetes and CKD.[13] A vast 
majority of patients with diabetes and kidney disease are 
under care of GPs in our part of the world owing to huge 
burden of the disease and lack of adequate number of 
nephrologists. Hence it needs to be ensured that our GPs 
are well versed in detection and management of diabetes 
and diabetic kidney disease.
Physicians involved in the care of CKD patients should pay 
attention to a wide range of disorders that may develop 
as a consequence of the loss of renal function. These 
include disorders of fluid and electrolyte balance, such 
as volume overload, hyperkalemia, metabolic acidosis, 
and hyperphosphatemia, as well as abnormalities related 
to hormonal or systemic dysfunction, such as anorexia, 
nausea, vomiting, fatigue, hypertension, anemia, 
malnutrition, hyperlipidemia, and bone disease. Onset 
and severity of these complications are related to the level 
of GFR. Below a GFR of approximately 60 ml/min, there is 
a higher prevalence of abnormalities of bone metabolism, 
anemia, malnutrition, and hypoalbuminemia. Other 
complications such as volume overload, hyperkalemia, 
and metabolic acidosis tend to occur when GFR falls 
below 15‑20 ml/min. Our results showed that most of 
the GPs recognized anemia, whereas bone disease and 
secondary hyperparathyroidism, as well as malnutrition, 
were identified as complications by only half of them. It is 
important to recognize these disorders as complications 
of CKD in order to reduce disease‑related morbidity and 
mortality.
Data from a number of epidemiologic studies have 
identified hypertension as a risk factor for progression 
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of CKD, and that from clinical trials confirm that 
antihypertensive treatment reduces the risk.[15] Apart 
from accelerating the progression of kidney disease, high 
BP leads to high risk of CVD including death. The Joint 
National Committee in their 7th report (JNC 7) and KDOQI 
guidelines recommend a target BP of < 130/80 mm 
Hg in patients with CKD.[16] It is alarming that a vast 
majority of GPs are not aware of the optimal systolic 
and diastolic BP for patients with kidney disease. Our 
findings are very similar to those from another study from 
Pakistan evaluating GPs’ approach toward hypertension in 
general population, indicating a similar degree of under 
treatment.[17] It was found that 47.7% of GPs aimed for 
a target BP > 140/90 in the general population, and 
the majority of GPs aimed for targets greater than those 
recommended by the JNC guidelines for patients with 
diabetes, kidney disease, and CVD.[17]
The KDOQI guidelines recommend ACE inhibitors and 
ARBs as the preferred agents for diabetic kidney disease 
and non‑diabetic kidney diseases with proteinuria.[16] In 
these diseases, they lower BP, reduce proteinuria, slow 
the progression of kidney disease, and likely reduce CVD 
risk by mechanisms in addition to lowering BP. There is 
substantial amount of evidence suggesting efficacy of this 
class of drugs in decreasing albuminuria, and delaying the 
progression from microalbuminuria to macroalbuminuria 
in patients with proteinuria and CKD.[18‑20] Almost half 
the GPs chose ACE inhibitors or ARBs as the first line 
of treatment to control BP and proteinuria followed by 
calcium channel blockers (34.9%), beta blockers (31%), 
and thiazide diuretics (29.7%). It is noteworthy that the 
GPs’ survey from Pakistan mentioned earlier had revealed 
that almost 45% of GPs used sedatives either alone or 
in combination with other antihypertensive agents as 
first‑line therapy for hypertension.[17] Keeping these 
observations in view, our survey indicates an improvement 
in prescribing practices of GPs as far as the management 
of hypertension is concerned.
All patients with a progressive increase in serum creatinine 
level need referral to a nephrologist, and preparation 
for renal replacement therapy ideally requires frequent 
contact with a nephrologist over at least a year. Compared 
with early referral, late referral has been found to be 
associated with a significantly increased risk of morbidity 
as well as all‑cause mortality. The potential benefits 
associated with early referral include informed selection 
of dialysis modality, timely placement of appropriate 
dialysis access, non‑emergent initiation of dialysis, lower 
morbidity and improved rehabilitation, less frequent and 
shorter hospital stays, lower cost, improved survival, 
and likelihood of preemptive transplant. In addition, 
timely referral provides opportunities for appropriate 
intervention that would eventually slow down the 
progression of CKD as well as reduce CVD risk. The KDOQI 
guidelines recommend that patients with CKD should be 
referred to a nephrologist when the eGFR is less than 60 
ml/min. In our survey, we found an uncertainty among 
our GPs about the appropriate time of referral. A vast 
majority of GPs were not aware as to when to refer a CKD 
patient to a nephrologist. Only 23% chose to refer when 
GFR was below 60 ml/min. Data from the USA and other 
developed as well as developing countries suggest that 
late referrals are quite common. One study has shown that 
approximately 25‑50% of patients beginning chronic renal 
replacement therapy in the USA require dialysis within 1 
month of their first nephrology visit.[21] In another study 
from Pakistan, almost half (48%) the study subjects 
were found to be unaware as to when to refer these 
patients to nephrologists based on eGFR, although a vast 
majority (84%) of the physicians knew that late referral 
would result in complications and higher morbidity and 
mortality.[11] Timely referrals to nephrologists can only 
be made when the primary care providers have a better 
understanding of the eGFR, including the level of GFR 
at which referral is recommended.
Our findings emphasize the need to increase the GPs’ 
awareness and knowledge of the evidence‑based CKD 
care as outlined in KDOQI guidelines. There is a need for 
continually updating the medical schools’ curricula as well 
as having structured and more frequent CME activities 
at teaching hospitals, especially targeting the GPs. In 
addition, knowledge regarding CKD can be improved by 
the use of posters and leaflets displayed in hospitals as 
well as by using the print (newspapers and journals) and 
the electronic media (radio and television). The KDOQI 
guidelines are quite extensive (over 200 pages) and 
hence are cumbersome to read. The responsibility lays 
with the physicians at the teaching hospitals, especially 
the nephrology community, to summarize the KDOQI 
guidelines into a one‑page educational tool providing the 
key evidence‑based practical points of the guidelines so 
that the GPs as well as other physicians involved in care 
of CKD patients could actually put them into practice. The 
key points that will help the GPs and internists improve 
their diagnosis and management of CKD are summarized 
in Table 1.
We noticed in our survey that most GPs were not aware 
of using eGFR to diagnose CKD. One simple solution 
could be requesting the laboratories to automatically 
report the eGFR (without an extra charge) whenever a 
serum creatinine is ordered. This is the current practice 
in most of the developed countries. However, physicians 
should be aware that GFR is influenced by age, gender, 
and race.
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The benefit of this study has a wider scope as updating 
the knowledge of GPs would lead to appropriate and 
timely diagnosis and management of patients with CKD. 
Furthermore, the limitations in knowledge and practice 
patterns of GPs will be communicated to the health 
authorities concerned with formulating appropriate 
recommendations for GPs, and thus they would be 
educated and quality of care to the community would 
be improved.
The limitations of our study are the small sample size 
and that the study was restricted to the GPs practicing 
in Karachi. Thus, it is not representative of GPs in other 
cities of the country, especially remote rural areas. A 
broader national survey would be needed to test the 
generalizability of our results. Another limitation could 
be the questionnaire that was kept short to ensure less 
time consumption while filling it. Thus, there were a 
few questions testing each aspect of CKD evaluation and 
management and this may less accurately evaluate the 
level of knowledge.
One should be aware that our study was designed to assess 
mainly the knowledge of GPs regarding diagnosis and care 
of patients with CKD. Hence, we cannot determine as to 
whether the proportion of GPs, who claimed to aim for 
correct diagnostic tools and management targets, would 
actually set those targets and practice them while treating 
those patients in real life. Also, we cannot determine the 
proportion of subjects who actually achieved those targets.
Conclusion
Our survey highlights the deficiencies and gaps in the 
knowledge and practices of GPs in Karachi regarding 
diagnosis and management of CKD. Educational efforts 
are needed to increase awareness of clinical practice 
guidelines and recommendations for patients with CKD 
among GPs, which may improve management and clinical 
outcomes of this population.
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Gender:  Male   Female
Location/Address: __________________________________________________________
Contact No.: _______________________________________________________________




1. How many patients visit your clinic per day?
 _______________________________________________________________________
2. Are you affiliated with any teaching hospital?
 1.  Yes  2.  No
3. Do you hold any postgraduate degree/diploma beyond MBBS?
 1.  Yes  2.  No
 If yes, please specify: ____________________________________________________
4. For how many years have you been practicing?
 _______________________________________________________________________
5.  Which population, do you think, is at high risk of developing chronic kidney disease (CKD)? (Tick all that apply)
 1.  Diabetic     2.  Have family history of CKD
 3.  Hypertensive    4.  Elderly (>60 years of age)
5. Others: ______________________________________________________________
6. When should patients with type 1 diabetes be screened for kidney disease?
 1.  At the time of diagnosis and annually thereafter
 2.  Five years after diagnosis and annually thereafter
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 3.  Yearly only
 4.  Never
 5.  Others _____________________________________________________
7. When should patients with type 2 diabetes be screened for kidney disease?
 1.  At the time of diagnosis and annually thereafter
 2.  Five years after diagnosis and annually thereafter
 3.  Yearly only
 4.  Never
 5.  Others _____________________________________________________
8. What is the best method to estimate kidney function? (Tick all that apply)
 1.  Serum creatinine/blood urea
 2.  Creatinine clearance (24‑h urine test)
 3.   Estimated glomerular filtration rate (eGFR) calculated from serum creatinine (based on Cockcroft–
Gault/MDRD equations)
 4.  Imaging (ultrasound of kidneys)
 5.  Any other test, please specify __________________________________
 __________________________________________________________________
9. What complications of CKD are you aware of? (Tick all that apply)
 1.  Anemia     2.  Ischemic heart disease
 3.  Hyperparathyroidism and bone disease 4.  Metabolic acidosis
 5.  Hyperkalemia    6.  Volume overload
 7.  Worsening hypertension   8.  Malnutrition
 9.  Others _____________________________________________________
10. What level of systolic blood pressure (mm of Hg) control do you target in a patient with CKD?
 1.  >140    2.  130‑139
 3.  110‑130    4.  <110
11. What level of diastolic blood pressure (mm of Hg) control do you target in a patient with CKD?
 1.  ≥90    2.  80‑89
 3.  60‑80    4.  <60
12. Which medications do you prescribe as first‑line antihypertensive agent for lowering BP in patients with proteinuria? 
(Tick all that apply)
 1.  Calcium channel blockers  2.  Beta‑blockers
 3.  ACE inhibitor/ARBs  4.  Thiazide diuretics
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 5.  Sedative    6.  Others ___________________
13. What level of HbA1c (%) do you target in diabetic patients with CKD?
 1.  <7.0    2.  Between 7 and 8
 3.  Between 8 and 9   4.  >9.0
14. What level of serum low‑density lipoprotein (LDL mg/dl) do you target in patients with CKD who do not have 
any clinical evidence of IHD?
 1.  >160    2.  130‑159
 3.  100‑129    4.  <100
 5.  Other _________________
15. At what level of GFR do you refer a patient with CKD to a nephrologist?
 1.  Between 30 and 60 ml/min 2.  Between 15 and 29 ml/min
 3.  Less than 15 ml/min  4.  Do not know
16. Do you read medical journals in order to keep yourself updated?
 1.  Yes    2. No
 If yes, name a few of them:
_____________________________________________________________________________________________________
_____________________________________________________________________________________________________
17. Do you participate in Continued Medical Education (CME) activities conducted at tertiary care hospitals?
 1.  Yes    2.  No
 If no, please specify the reason: __________________________________________________________________
* Thanks for your time *
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